STRYKER CORP Finite-Lived Intangible Asset, Expected Amortization, Year One
STRYKER CORP (SYK) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $715.00 million as of 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2026-07-31
- 2026-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $715.00M.
- 2026-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $682.00M.
- 2025-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $699.00M.
- 2025-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $697.00M.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2026-06-30 | $715.00M 10-Q · filed 2026-07-31 |
| 2026-03-31 | $682.00M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $699.00M 10-K · filed 2026-02-11 |
| 2025-09-30 | $697.00M 10-Q · filed 2025-10-31 |
| 2025-06-30 | $693.00M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $695.00M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $605.00M 10-K · filed 2025-02-12 |
| 2024-09-30 | $648.00M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $597.00M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $593.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $622.00M 10-K · filed 2024-02-14 |
| 2023-09-30 | $607.00M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $608.00M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $590.00M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $620.00M 10-K · filed 2023-02-10 |
| 2022-09-30 | $617.00M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $620.00M 10-Q · filed 2022-07-27 |
| 2022-03-31 | $624.00M 10-Q · filed 2022-04-29 |
| 2021-12-31 | $581.00M 10-K · filed 2022-02-11 |
| 2021-09-30 | $577.00M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $588.00M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $588.00M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $600.00M 10-K · filed 2021-02-11 |
| 2020-09-30 | $446.00M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $442.00M 10-Q · filed 2020-07-31 |
| 2015-12-31 | $202.00M 10-K · filed 2016-02-11 |
| 2015-09-30 | $51.00M 10-Q · filed 2015-10-23 |
| 2015-06-30 | $100.00M 10-Q · filed 2015-07-29 |
| 2015-03-31 | $150.00M 10-Q · filed 2015-04-30 |
| 2014-12-31 | $196.00M 10-K · filed 2015-02-12 |
| 2013-12-31 | $167.00M 10-K · filed 2014-02-13 |
| 2012-12-31 | $117.00 10-K · filed 2013-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |